🚀 VC round data is live in beta, check it out!
Arjo Valuation Multiples
Discover revenue and EBITDA valuation multiples for Arjo and similar public comparables like Gerresheimer, Salus, Paul Hartmann, Embecta and more.
Arjo Overview
About Arjo
Arjo AB is a supplier of medical devices, services, and solutions in Sweden. It serves its services to private and public institutions with acute care and long-term care. The company's offering includes products and solutions for patient handling, hygiene, disinfection, medical beds, therapeutic surfaces, venous thromboembolism (VTE) prevention and diagnostics. It also offers services such as training in connection with product sales. Geographically, it derives a majority of revenue from Western Europe and also has a presence in North America; and the Rest of the World.
Founded
1957
HQ
Employees
7.2K
Website
Sectors
Financials (LTM)
EV
$1B
Arjo Financials
Arjo reported last 12-month revenue of $1B and EBITDA of $213M.
In the same LTM period, Arjo generated $522M in gross profit, $213M in EBITDA, and $41M in net income.
Revenue (LTM)
Arjo P&L
In the most recent fiscal year, Arjo reported revenue of $1B and EBITDA of $215M.
Arjo expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | $522M | XXX | $503M | XXX | XXX | XXX |
| Gross Margin | 43% | XXX | 40% | XXX | XXX | XXX |
| EBITDA | $213M | XXX | $215M | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 17% | XXX | XXX | XXX |
| EBIT Margin | 7% | XXX | 7% | XXX | XXX | XXX |
| Net Profit | $41M | XXX | $38M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 3% | XXX | XXX | XXX |
| Net Debt | — | — | $349M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Arjo Stock Performance
Arjo has current market cap of $736M, and enterprise value of $1B.
Market Cap Evolution
Arjo's stock price is $2.70.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $736M | -5.5% | XXX | XXX | XXX | $0.14 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialArjo Valuation Multiples
Arjo trades at 1.0x EV/Revenue multiple, and 5.7x EV/EBITDA.
EV / Revenue (LTM)
Arjo Financial Valuation Multiples
As of April 11, 2026, Arjo has market cap of $736M and EV of $1B.
Equity research analysts estimate Arjo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Arjo has a P/E ratio of 17.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $736M | XXX | $736M | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | 5.7x | XXX | 5.7x | XXX | XXX | XXX |
| EV/EBIT | 14.1x | XXX | 13.7x | XXX | XXX | XXX |
| EV/Gross Profit | 2.3x | XXX | 2.4x | XXX | XXX | XXX |
| P/E | 17.8x | XXX | 19.5x | XXX | XXX | XXX |
| EV/FCF | 18.8x | XXX | 15.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Arjo Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Arjo Margins & Growth Rates
Arjo's revenue in the last 12 month declined by (3%).
Arjo's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Arjo's rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Arjo's rule of X is 17% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Arjo Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | (3%) | XXX | (5%) | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 17% | XXX | XXX | XXX |
| EBITDA Growth | (1%) | XXX | (3%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 17% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 17% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 20% | XXX | 20% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 13% | XXX | 13% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 1% | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 33% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Arjo Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Gerresheimer | XXX | XXX | XXX | XXX | XXX | XXX |
| Salus | XXX | XXX | XXX | XXX | XXX | XXX |
| Paul Hartmann | XXX | XXX | XXX | XXX | XXX | XXX |
| Embecta | XXX | XXX | XXX | XXX | XXX | XXX |
| BioLife Solutions | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Arjo M&A Activity
Arjo acquired XXX companies to date.
Last acquisition by Arjo was on XXXXXXXX, XXXXX. Arjo acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Arjo
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialArjo Investment Activity
Arjo invested in XXX companies to date.
Arjo made its latest investment on XXXXXXXX, XXXXX. Arjo invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Arjo
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Arjo
| When was Arjo founded? | Arjo was founded in 1957. |
| Where is Arjo headquartered? | Arjo is headquartered in Sweden. |
| How many employees does Arjo have? | As of today, Arjo has over 7K employees. |
| Who is the CEO of Arjo? | Arjo's CEO is Niclas Sjosward. |
| Is Arjo publicly listed? | Yes, Arjo is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Arjo? | Arjo trades under ARJO B ticker. |
| When did Arjo go public? | Arjo went public in 2017. |
| Who are competitors of Arjo? | Arjo main competitors are Gerresheimer, Salus, Paul Hartmann, Embecta. |
| What is the current market cap of Arjo? | Arjo's current market cap is $736M. |
| What is the current revenue of Arjo? | Arjo's last 12 months revenue is $1B. |
| What is the current revenue growth of Arjo? | Arjo revenue growth (NTM/LTM) is (3%). |
| What is the current EV/Revenue multiple of Arjo? | Current revenue multiple of Arjo is 1.0x. |
| Is Arjo profitable? | Yes, Arjo is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Arjo? | Arjo's last 12 months EBITDA is $213M. |
| What is Arjo's EBITDA margin? | Arjo's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Arjo? | Current EBITDA multiple of Arjo is 5.7x. |
| What is the current FCF of Arjo? | Arjo's last 12 months FCF is $65M. |
| What is Arjo's FCF margin? | Arjo's last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of Arjo? | Current FCF multiple of Arjo is 18.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.